Heavily-backed start-up now selling Ozempic, the buzzy weight loss drug.
Company argues its other medication, Saxenda, is in short supply.
Government drug regulator says Ozempic is scarce, not Saxenda.
Australia’s biggest weight loss drug selling start-up, Eucalyptus, has begun selling Ozempic after previously insisting it only sold medications specifically approved to help people shed kilograms.
Ozempic has been linked to weight loss by a host of celebrities and influencers but is only recommended in Australia as a treatment for type 2 diabetes.
Loading...
Nick Bonyhady is a technology writer for the Australian Financial Review, based in Sydney. He is a former technology editor, industrial relations and politics reporter at the Sydney Morning Herald and Age. Connect with Nick on Twitter. Email Nick at nick.bonyhady@afr.com
